The DNA damage response induces antigen presenting cell-like functions in fibroblasts

European Journal of Immunology

Volumn 44, Issue 4, 2014, Pages 1108-1118

  Tang, Melissa Li Fang ^a   Khan, Muznah Khatoo Nazar ^a   Croxford, John Ludovic ^a   Tan, Kar Wai ^a   Angeli, Veronique ^a   Gasser, Stephan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adaptive immunity; Antigen presenting cell; Chemotherapy; DNA damage; Fibroblasts

Indexed keywords

CYTARABINE; HYDROGEN PEROXIDE; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NATURAL KILLER CELL RECEPTOR NKG2D; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA DAMAGE; FIBROBLAST; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; LUNG METASTASIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA B16; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADAPTIVE IMMUNITY; ANTIGEN-PRESENTING CELL; CHEMOTHERAPY; DNA DAMAGE; FIBROBLASTS;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BENZENEACETAMIDES; BLOTTING, WESTERN; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTARABINE; DENDRITIC CELLS; DNA DAMAGE; FIBROBLASTS; FLOW CYTOMETRY; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; THIOUREA;

EID: 84897969175     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343781     Document Type: Article

References (41)

1. Hanahan, D. and Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011. 144: 646-674.
2. Branzei, D. and Foiani, M., Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell. Biol. 2010. 11: 208-219.
3. Halazonetis, T. D., Gorgoulis, V. G. and Bartek, J., An oncogene-induced DNA damage model for cancer development. Science 2008. 319: 1352-1355.
4. Ciccia, A., McDonald, N. and West, S. C., Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 2008. 77: 259-287.
5. Jackson, S. P. and Bartek, J., The DNA-damage response in human biology and disease. Nature 2009. 461: 1071-1078.
6. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaccmaz, K. and Linn, S., Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004. 73: 39-85.
7. Gasser, S., Orsulic, S., Brown, E. J. and Raulet, D. H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005. 436: 1186-1190.
8. Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M. et al., ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009. 113: 3503-3511.
9. Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Kletsas, D., Mariatos, G., Zoumpourlis, V., Ryan, K. M. et al., p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J. 2003. 22: 1567-1578.
10. Gasser, S. and Raulet, D., The DNA damage response, immunity and cancer. Semin. Cancer Biol. 2006. 16: 344-347.
11. Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T. et al., DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996. 4: 573-581.
12. Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R. and Raulet, D., The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002. 17: 19-29.
13. Shibuya, K., Lanier, L. L., Phillips, J. H., Ochs, H. D., Shimizu, K., Nakayama, E., Nakauchi, H. et al., Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999. 11: 615-623.
14. Shibuya, K., Shirakawa, J., Kameyama, T., Honda, S., Tahara-Hanaoka, S., Miyamoto, A., Onodera, M. et al., CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 2003. 198: 1829-1839.
15. Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W. and Jung, H., Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 2013. 31: 413-441.
16. Bluthmann, H., Kisielow, P., Uematsu, Y., Malissen, M., Krimpenfort, P., Berns, A., von Boehmer, H. et al., T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes. Nature 1988. 334: 156-159.
17. Meyron-Holtz, E. G., Ghosh, M. C. and Rouault, T. A., Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 2004. 306: 2087-090.
18. Ames, B. N., Endogenous oxidative DNA damage, aging, and cancer. Free Radic. Res. Commun. 1989. 7: 121-128.
19. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K. et al., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 2009. 15: 1170-1178.
20. Aymeric, L., Apetoh, L., Ghiringhelli, F., Tesniere, A., Martins, I., Kroemer, G., Smyth, M. J. et al., Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer. Res. 2010. 70: 855-858.
21. Bevan, M. J., The earliest knockouts. J. Immunol. 2010. 184: 4585-4586.
22. Met, O., Buus, S. and Claesson, M. H., Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC. Cell. Immunol. 2003. 222: 126-133.
23. Rahemtulla, A., Fung-Leung, W. P., Schilham, M. W., Kundig, T. M., Sambhara, S. R., Narendran, A., Arabian, A. et al., Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991. 353: 180-184.
24. Fraser, C. K., Lousberg, E. L., Guerin, L. R., Hughes, T. P., Brown, M. P., Diener, K. R. and Hayball, J. D., Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo. Cancer Biol. Ther. 2010. 10: 715-727.
25. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
26. Janeway, C. A., Jr. and Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 2002. 20: 197-216.
27. Tseng, S. Y. and Dustin, M. L., T-cell activation: a multidimensional signaling network. Curr. Opin. Cell. Biol. 2002. 14: 575-580.
28. Simpson, T. R., Quezada, S. A. and Allison, J. P., Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr. Opin. Immunol. 2010. 22: 326-332.
29. Denucci, C. C., Mitchell, J. S. and Shimizu, Y., Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there. Crit. Rev. Immunol. 2009. 29: 87-109.
30. Xu, Z. and Jin, B., A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell. Mol. Immunol. 2010. 7: 11-19.
31. Gilfillan, S., Chan, C. J., Cella, M., Haynes, N. M., Rapaport, A. S., Boles, K. S., Andrews, D. M. et al., DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J. Exp. Med. 2008. 205: 2965-2973.
32. Zijlstra, M., Bix, M., Simister, N., Loring, J., Raulet, D. and Jaenisch, R., b2-Microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990. 344: 742-746.
33. Wang, P., Raynoschek, C., Svensson, K. and Ljunggren, H. G., Binding of H-2Kb-specific peptides to TAP and major histocompatibility complex class I in microsomes from wild-type, TAP1, and beta2-microglobulin mutant mice. J. Biol. Chem. 1996. 271: 24830-24835.
34. Hughes, E. A., Hammond, C. and Cresswell, P., Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. U. S. A. 1997. 94: 1896-1901.
35. Bevan, M. J., Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 2004. 4: 595-602.
36. Tyznik, A. J., Sun, J. C. and Bevan, M. J., The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 2004. 199: 559-565.
37. Lander, M. R., Moll, B. and Rowe, W. P., A procedure for culture of cells from mouse tail biopsies: brief communication. J. Natl. Cancer Inst. 1978. 60: 477-478.
38. Dardalhon, V., Schubart, A. S., Reddy, J., Meyers, J. H., Monney, L., Sabatos, C. A., Ahuja, R. et al., CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J. Immunol. 2005. 175: 1558-1565.
39. Wong, K. L., Tang, L. F., Lew, F. C., Wong, H. S., Chua, Y. L., MacAry, P. A. and Kemeny, D. M., CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production. J. Immunol. 2009. 183: 41-50.
40. Salagianni, M., Wong, K. L., Thomas, M. J., Noble, A. and Kemeny, D. M., An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses. J. Immunol. 2007. 178: 4771-4778.
41. Grotenbreg, G. M., Roan, N. R., Guillen, E., Meijers, R., Wang, J. H., Bell, G. W., Starnbach, M. N. et al., Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. U. S. A. 2008. 105: 3831-3836.